Demand backed by the NHS backlog

For One Health Group (LSE:OHGR), the scale of NHS waiting lists is the backdrop that underpins demand, and it shapes the FTSE AIM All-Share company's growth. One Health provides elective surgery and community musculoskeletal services to NHS patients under outsourcing arrangements, helping the health service treat people who might otherwise wait longer. As long as NHS waiting lists remain elevated, there is structural Demand for independent-sector capacity of the kind One Health offers. In 2025 the company also switched its listing from the Aquis exchange to AIM, raising around £8m in the process.

Consistent growth

The full-year results for the year to 31 March 2026 continued a run of expansion. Revenue rose 11% to £31.6m, adjusted EBITDA increased 28% to £2.6m, and the company ended the year with cash of £11.1m, proposing a Dividend of 6.3p, according to its reporting. This marked a fifth consecutive year of growth. These are reported figures. The company also had its first owned surgical hub under construction, which it expects to add capacity from the 2027 or 2028 financial years, pointing to a route to further growth beyond its existing outsourced model.

From outsourcing to owned capacity

One Health's established model uses NHS and partner facilities to deliver care, keeping Capital requirements relatively low. The move to build its own surgical hub represents a step change: owning capacity could increase capacity and margins over time, but it also commits capital and carries construction and utilisation risk. The transition from an asset-light outsourcer to an operator of its own Facility is a strategic evolution that shareholders will watch, since it changes both the growth potential and the risk profile of the Business as the hub comes on stream. The Economics rest on a simple premise: as long as NHS waiting lists stay high, commissioners have reason to route elective patients to independent-sector capacity, and One Health is positioned to take that work. The step to build its own surgical hub is the most consequential strategic decision in years, because owning capacity could lift both volumes and margins from the 2027 or 2028 financial years, while committing capital and adding construction and utilisation risk to a previously asset-light model. A proposed dividend of 6.3p and year-end cash of £11.1m give the company the means to invest while still returning some cash. NHS policy stays decisive.

Opportunities and risks

The opportunity is durable demand driven by NHS waiting lists, a track record of steady growth, a dividend, and the prospect of higher capacity and margins from owned surgical hubs. The risks are meaningful. The business depends heavily on NHS commissioning and funding policy, which can change with budgets and politics, and on maintaining contracts and clinical standards. Building and filling an owned hub carries execution and utilisation risk. As a small AIM company, it is more exposed to individual contracts and less liquid than larger peers. Waiting-list dynamics could also shift with NHS capacity investment.

The bottom line

NHS waiting lists shape One Health Group by underpinning demand for the independent-sector elective care it provides. The year to March 2026 delivered a fifth straight year of growth, with revenue up 11%, higher EBITDA, a solid cash position and a dividend, alongside a first owned surgical hub under construction. For readers, the questions are whether NHS outsourcing demand and funding remain supportive, whether the owned-hub strategy delivers, and how contract dependence is managed. The waiting-list backdrop gives the company a clear demand rationale, but reliance on NHS policy and the shift to owned capacity are the key variables for shareholders over time.